Metraipolis › archive › dc_0e010fbc01d6

Controlled Release Technologies for Diltiazem Hydrochloride: A Comprehensive Review of Solid Dosage Innovations — Europe PMC PMID:41304827

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41304827
DOI
10.3390/pharmaceutics17111491
License (as archived)
solo-consultazione
Archived
2026-11-08T10:16:19.015Z
SHA-256 of the archived text
4c32db29721b4b08c9169556a02bd48315f1d454dcb4988e168f9e2deefc6ea6
Stable URL of this page
https://metraipolis.com/documento/dc_0e010fbc01d6

How to cite

Controlled Release Technologies for Diltiazem Hydrochloride: A Comprehensive Review of Solid Dosage Innovations — Europe PMC PMID:41304827 — Europe PMC (en), https://europepmc.org/article/MED/41304827 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0e010fbc01d6 (Metraipolis archive dc_0e010fbc01d6, sha256 4c32db29721b4b08c9169556a02bd48315f1d454dcb4988e168f9e2deefc6ea6)
BibTeX
@misc{dc0e010fbc01d6,
  title = {Controlled Release Technologies for Diltiazem Hydrochloride: A Comprehensive Review of Solid Dosage Innovations — Europe PMC PMID:41304827},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41304827},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0e010fbc01d6; sha256 4c32db29721b4b08c9169556a02bd48315f1d454dcb4988e168f9e2deefc6ea6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41304827. Agents can read the archived copy with the MCP tool read_document.